Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

idt Abfüllanlage
© Hartmut Bösener/IDT Biologika

First clinical trial of DZIF vaccine against COVID-19 gets go-ahead

The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, today approved the clinical trial of the MVA-SARS-2-S vaccine against COVID-19. The vector vaccine was developed by

Laborarbeit
© FZ Borstel/Pukall

Tuberculosis: new type of test rapidly and clearly detects resistance

An international team managed by scientists at the Research Center Borstel and the German Center for Infection Research (DZIF) have examined a new method for detecting resistant tuberculosis strains

SARS-CoV-2
© NIAID

COVID-19: Immune system derails

Bonn, 6. August 2020. Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction – rather, the immune response is caught in a

Stephan Urban
© Universitätsklinikum Heidelberg

First drug for hepatitis D has been approved by European Commission

Joint press release from Heidelberg University and the German Center for Infection Research (DZIF)

What started off as basic research 25 years ago has now led to a successfully approved drug: The

LEOSSsero-survey logo
© HZI

How many people are now immune to SARS-CoV-2?

Who has overcome an infection with the virus without noticing, and how many people have already produced protective antibodies against the new coronavirus? Various antibody studies are now under way

Menschliche Pockenviren
© CDC/Dr. Fred Murphy

Even the Vikings had smallpox

The smallpox virus was already circulating in Northern Europe in the 7th century. This is indicated by DNA from Viking skeletons that researchers from Charité - Universitätsmedizin Berlin, including

Staphylococcus aureus
© NIAID

Siblings can also differ from one another in bacteria

A research team from the University of Tübingen and the German Center for Infection Research (DZIF) is investigating how pathogens influence the immune response of their host with genetic variation

Florian Klein, Matthias Zehner and Christoph Kreer
© Dorothea Hensen / Uniklinik Köln

Neutralising antibodies in the battle against COVID-19

An important line of defence in the fight against the new corona virus SARS-CoV-2 is the formation of neutralising antibodies. These can eliminate the intruders and have great potential to be used for

Lunge mit NTM
© FZ Borstel

International recommendations for nontuberculous mycobacteria

After 13 years, international Infectious Diseases and Respiratory Medicine societies have jointly issued new recommendations for the treatment of patients with nontuberculous mycobacteria (NTM). Curre

Starkes Team aus München
© Kilian Schober

The tricks of the immune system

More than half of the world's population is infected with the cytomegalovirus. The majority of people don't even notice the infection, since their immune systems keep the virus in check. Groups of T